---
accession : E-GEOD-13487
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 cell line
treatment : 1 uM BAY-43-9006
effect    : inhibiting
hours     : 24

control   :
    - GSE13487GSM339978
    - GSE13487GSM339980
perturbed :
    - GSE13487GSM339966
    - GSE13487GSM339967

---
accession : E-GEOD-13487
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 cell line
treatment : 1 uM Raf inhibitor
effect    : inhibiting
hours     : 24

control   :
    - GSE13487GSM339978
    - GSE13487GSM339980
perturbed :
    - GSE13487GSM339960
    - GSE13487GSM339961

---
accession : E-GEOD-13487
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 cell line shB-Raf (doxycycline inducible)
treatment : doxycycline
effect    : inhibiting
hours     : 48

control   :
    - GSE13487GSM339971 # no perturbed
    - GSE13487GSM339974
    - GSE13487GSM339977
    - GSE13487GSM339979 # DMSO
    - GSE13487GSM339981
perturbed :
    - GSE13487GSM339983
    - GSE13487GSM339984
    - GSE13487GSM339986
    - GSE13487GSM339987
    - GSE13487GSM339989

---
accession : E-GEOD-13487
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 cell line shB-Raf (doxycycline inducible)
treatment : 1 uM BAY-43-9006
effect    : inhibiting
hours     : 24

control   :
    - GSE13487GSM339979
    - GSE13487GSM339981
perturbed :
    - GSE13487GSM339968
    - GSE13487GSM339969

---
accession : E-GEOD-13487
platform  : A-AFFY-44
pathway   : MAPK
cells     : A375 cell line shB-Raf (doxycycline inducible)
treatment : 1 uM Raf inhibitor
effect    : inhibiting
hours     : 24

control   :
    - GSE13487GSM339979
    - GSE13487GSM339981
perturbed :
    - GSE13487GSM339962
    - GSE13487GSM339963
...
